Compared with untreated and UT-T controls, all mice treated with 5×105 CT83/TCR1-Ts displayed tumor regression, and the tumors regressed more obviously at a higher dose of 5×106 CT83/TCR1-Ts, showing a tumor growth curve and tumor samples extracted on day 27 (figure 5B). Here, CT83 is linked to neoplasm.